Summary

On 11 March 2020, the World Health Organization declared COVID-19 a global pandemic, and the disease now affects nearly every country and region. Caused by SARS-CoV-2, COVID-19 continues nearly 18 months later to present significant challenges to health systems and public health in both hemispheres, as well as the economies of every country. The morbidity and mortality of the infection caused by SARS-CoV-2 has been significant, and various waves of disease outbreaks initially overwhelmed many hospitals and clinics and continue to do so in many countries. This influences everyone, and public health countermeasures have been dramatic in terms of their impact on employment, social systems, and mental health. This entry collection aims to gather diverse fields about COVID-19, including in epidemiology, public health, medicine, genetics, systems biology, informatics, data science, engineering, sociology, anthropology, nursing, environmental studies, statistics, and psychology.

Expand All
Entries
Topic Review
COVID-19 on Sexual&Reproductive Health
The emergence of the coronavirus disease 2019 (COVID-19) pandemic has rapidly transformed the pre-existing worldwide sexual and reproductive health environment. The provision and supply of contraceptives, and a wide variety of sexual health, new-born, and maternal health services have been seriously affected. Thus, this scoping review mapped the available evidence on the impacts of the COVID-19 outbreak on sexual and reproductive health. 
  • 437
  • 20 Apr 2021
Topic Review
Cardiovascular Complications Associated with COVID-19
An infectious coronavirus disease 2019 (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is accompanied with elevated risk and adverse outcome among infected patients, even sudden death due to significant multiple organ dysfunction, including dire cardiovascular complications. Myocardial impairment due to invasion of SARS-CoV-2 virus via angiotensin-converting enzyme 2 receptor to cardiovascular cells/tissue leads to endothelial inflammation and dysfunction, de-stabilization of vulnerable atherosclerotic plaques, stent thrombosis and cardiac stress, caused by diminished oxygen supply and cardiac muscle damage and myocardial infarction. A number of promising therapeutic approaches are currently under clinical trials to avoid a massive surge of COVID-19 patients with prevalence of adverse cardiac events.
  • 1.1K
  • 19 Apr 2021
Topic Review
Saliva and SARS-CoV-2
A novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak has become a global ongoing pandemic. This pandemic represents a great work risk for all health professionals, it includes dental professionals who are in constant contact with saliva, which represents one of the main routes of transmission of the disease. For several decades, saliva has been continuously studied as a means of assessing human health because it contains a wide variety of biomarkers. This is because saliva is a mixture of fluids from the salivary glands, crevicular fluids, desquamated epithelial cells, microorganisms, and a great number of proteins such as immunoglobulins, hormones, enzymes, and cytokines. Besides, a wide variety of oral tissues and cells are susceptible to infection by SARS-CoV-2 and that they express the ACE2 receptor, which is the main route of entry of the virus into cells, as well as the proteins TMPRSS and furin that contributes to the binding of the virus to the host cells.
  • 393
  • 14 Apr 2021
Topic Review
Nanofiber-Based Face Masks and Respirators
Wearing face masks, use of respirators, social distancing, and practicing personal hygiene are all measures to prevent the spread of coronavirus disease (COVID-19). This pandemic has revealed the deficiency of face masks and respirators across the world. Therefore, significant efforts are needed to develop air filtration and purification technologies, as well as innovative, alternative antibacterial and antiviral treatment methods. It has become urgent—in order for humankind to have a sustainable future—to provide a feasible solution to air pollution, particularly to capture fine inhalable particulate matter in the air.
  • 716
  • 24 Aug 2021
Topic Review
Lactiplantibacillus plantarum and SARS-CoV-2 Vaccine
Lactiplantibacillus plantarum (Basonym Lactobacillus plantarum) is a good candidate for developing oral vaccines because it survives gastrointestinal conditions transiently colonizing the intestinal tract, it beneficially modulates the mucosal immune responses not only locally (intestinal mucosa) but in distant mucosal sites as well (respiratory mucosa) and there are molecular techniques available for the manipulation of its genome.
  • 642
  • 14 Apr 2021
Topic Review
Demand Creation for COVID-19 Vaccination
As more approved COVID-19 vaccines are made available and supply meets or exceeds demand, medical and public health professionals will increasingly be faced with the challenge of vaccine hesitancy. This article describes a demand creation strategy to overcome COVID-19 vaccine hesitancy using methods and evidence from behavioral science and social marketing, and describes a specific campaign aimed at increasing vaccination rates in high supply settings.
  • 720
  • 13 Apr 2021
Topic Review Peer Reviewed
COVID-19 and Coronary Heart Disease
Coronary heart disease (CHD) is the leading cause of mortality worldwide. One of the main contributions of mortality and morbidity in CHD patients is acute myocardial infarction (AMI), which is the result of abrupt occlusion of an epicardial coronary artery due to a sudden rupture of atherosclerotic plaque, causing myocardial ischemia. In the initial stage of myocardial ischemia, lack of oxygen and nutrient supply results in biochemical and metabolic changes within the myocardium. Depletion of oxygen switches the aerobic cellular metabolism to anaerobic metabolism and impairs the oxidative phosphorylation pathway eventually leading to cardiomyocyte death. Several studies suggest an interlink between COVID-19 and ischemic heart disease. An increased ACE2 receptor expression in the myocardium may partly contribute to the myocardial injuries that are observed in patients affected by SARS-CoV-2. Furthermore, pre-existing cardiovascular disease, in conjunction with an aggravated inflammatory response which causes an up-regulation in pro-inflammatory cytokines. Moreover, patients with atherosclerosis are observed to be more prone to ischemic attacks when affected by COVID-19, due to hypercoagulation in the blood as well as elevated pro-inflammatory markers.
  • 548
  • 13 Apr 2022
Topic Review
Resveratrol in COVID-19-Associated Hemostatic Disorders
By virtue of its anti-thrombotic and anti-inflammatory properties, resveratrol would be expected to lower COVID-19-associated mortality, which is well known to be increased by thrombosis and inflammation.
  • 675
  • 01 Apr 2021
Topic Review
COPD’s Patients in COVID-19 Pandemic
For the treatment of chronic obstructive pulmonary disease (COPD), early diagnosis and unconditionally correct management at the initial stage of the disease are very important when the symptoms are not yet too worrying. In this way, the progress of the disease can be slowed down, as can the occurrence of late, life-threatening symptoms. Pulmonary rehabilitation is an essential component of the management of COPD. The selection of appropriate exercises, which are determined during the classification of patients into a suitable improvement program, is of key importance in the process of rehabilitation. 
  • 495
  • 30 Mar 2021
Topic Review
The Pandemic City
Pandemics have shaped the way cities are planned and configured. Throughout history, cities have evolved to solve problems of sanitation, hygiene, and health access while providing space and opportunities for the urban dwellers.
  • 698
  • 30 Mar 2021
  • Page
  • of
  • 74
>>